NORGES BANK - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 172 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORGES BANK ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$29,107,000
+1.2%
2,339,750
+6.4%
0.01%
-7.1%
Q3 2016$28,766,000
+90.4%
2,200,020
+7.6%
0.01%
+100.0%
Q2 2016$15,105,000
+41.9%
2,043,993
+22.7%
0.01%
+40.0%
Q1 2016$10,645,000
+2.2%
1,665,9930.0%0.01%0.0%
Q4 2015$10,412,000
+7.0%
1,665,9930.0%0.01%0.0%
Q3 2015$9,729,000
-23.8%
1,665,993
+7.9%
0.01%
-16.7%
Q2 2015$12,764,000
+19.6%
1,543,444
+19.2%
0.01%
+20.0%
Q1 2015$10,668,000
+3.8%
1,294,722
-13.4%
0.01%0.0%
Q4 2014$10,273,000
-10.4%
1,495,354
-29.6%
0.01%
-16.7%
Q3 2014$11,465,000
-57.6%
2,123,115
-50.0%
0.01%
-14.3%
Q2 2014$27,050,000
+58.1%
4,246,230
+100.0%
0.01%
-30.0%
Q1 2014$17,113,000
+18.2%
2,123,1150.0%0.01%
+25.0%
Q4 2013$14,480,000
-69.3%
2,123,115
-17.1%
0.01%
-70.4%
Q3 2013$47,101,000
+251.9%
2,559,796
+234.5%
0.03%
+237.5%
Q2 2013$13,385,000
+24.4%
765,307
+28.6%
0.01%
+14.3%
Q1 2013$10,762,000
-17.2%
594,889
+10.8%
0.01%
-22.2%
Q3 2012$13,002,000
+33.2%
536,719
+5.2%
0.01%
+12.5%
Q2 2012$9,761,000510,2080.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$94,961,00026.95%
Consonance Capital Management LP 8,845,742$65,370,0009.25%
Opaleye Management Inc. 1,250,000$9,238,0006.17%
Tamarack Advisers, LP 2,100,000$15,519,0005.95%
IRONWOOD INVESTMENT MANAGEMENT LLC 293,352$2,168,0001.62%
Camber Capital Management LP 4,000,000$29,560,0001.43%
Palo Alto Investors LP 2,535,117$18,735,0001.42%
Granite Point Capital Management, L.P. 430,890$3,184,0001.37%
1492 Capital Management LLC 202,500$1,496,0001.34%
HighVista Strategies LLC 869,100$6,423,0001.23%
View complete list of ARIAD PHARMACEUTICALS INC shareholders